Header Logo

Neilayan Sen

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
3
2019
14
0.450
 Why?
Pancreatic Neoplasms
1
2014
88
0.410
 Why?
Employment
2
2018
40
0.280
 Why?
Chemoradiotherapy
2
2019
57
0.260
 Why?
Internship and Residency
2
2019
208
0.230
 Why?
Sarcoma
2
2019
143
0.230
 Why?
Carcinoma, Non-Small-Cell Lung
2
2017
236
0.210
 Why?
Lung Neoplasms
2
2017
543
0.180
 Why?
Human papillomavirus 16
1
2019
6
0.160
 Why?
Oropharyngeal Neoplasms
1
2019
19
0.150
 Why?
Biopsy, Fine-Needle
1
2019
63
0.150
 Why?
Career Choice
1
2018
24
0.150
 Why?
Tongue Neoplasms
1
2018
18
0.150
 Why?
Neoadjuvant Therapy
2
2019
63
0.150
 Why?
Carcinoma, Squamous Cell
1
2019
165
0.140
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
242
0.130
 Why?
Radiosurgery
1
2017
33
0.130
 Why?
Prognosis
2
2019
784
0.120
 Why?
Brachytherapy
1
2016
44
0.120
 Why?
Radiotherapy, Adjuvant
1
2014
51
0.110
 Why?
Humans
10
2019
25967
0.100
 Why?
United States
4
2019
1989
0.100
 Why?
Retrospective Studies
4
2019
3358
0.080
 Why?
Treatment Outcome
4
2019
3399
0.080
 Why?
Male
6
2019
14277
0.070
 Why?
Chi-Square Distribution
2
2018
137
0.070
 Why?
Female
6
2019
14734
0.070
 Why?
Disease-Free Survival
2
2018
174
0.070
 Why?
Databases, Factual
2
2019
337
0.060
 Why?
Adult
4
2019
7662
0.060
 Why?
Neoplasm Staging
2
2018
360
0.060
 Why?
Cohort Studies
2
2019
1806
0.050
 Why?
Aged
3
2019
8732
0.040
 Why?
Genetic Heterogeneity
1
2019
9
0.040
 Why?
Mesna
1
2019
3
0.040
 Why?
Population Density
1
2018
7
0.040
 Why?
Job Application
1
2018
6
0.040
 Why?
Ifosfamide
1
2019
13
0.040
 Why?
Cities
1
2018
15
0.040
 Why?
Clinical Decision-Making
1
2019
45
0.040
 Why?
Organ Sparing Treatments
1
2019
12
0.040
 Why?
Reference Values
1
2019
181
0.040
 Why?
Leg
1
2019
46
0.040
 Why?
Schools, Medical
1
2018
26
0.040
 Why?
Consumer Behavior
1
2018
23
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2018
29
0.040
 Why?
Doxorubicin
1
2019
57
0.040
 Why?
Arm
1
2019
83
0.040
 Why?
Neoplasm Invasiveness
1
2018
91
0.040
 Why?
Combined Modality Therapy
1
2019
297
0.040
 Why?
Analysis of Variance
1
2018
252
0.040
 Why?
Survival Rate
1
2018
333
0.030
 Why?
Professional Practice Location
1
2017
2
0.030
 Why?
Academies and Institutes
1
2017
11
0.030
 Why?
Censuses
1
2017
9
0.030
 Why?
Radiotherapy Dosage
1
2017
97
0.030
 Why?
Patient Safety
1
2017
36
0.030
 Why?
Kaplan-Meier Estimate
1
2017
174
0.030
 Why?
Risk Assessment
1
2019
603
0.030
 Why?
Societies, Medical
1
2017
123
0.030
 Why?
Registries
1
2017
192
0.030
 Why?
Age Factors
1
2018
757
0.030
 Why?
Middle Aged
2
2019
8772
0.030
 Why?
Chemoradiotherapy, Adjuvant
1
2015
16
0.030
 Why?
Survival Analysis
1
2015
258
0.030
 Why?
Surveys and Questionnaires
1
2018
1107
0.030
 Why?
Adolescent
1
2018
2099
0.020
 Why?
Young Adult
1
2018
1941
0.020
 Why?
Prospective Studies
1
2017
1701
0.020
 Why?
Follow-Up Studies
1
2017
1757
0.020
 Why?
Aged, 80 and over
1
2017
4641
0.020
 Why?
Sen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_